Ligand validation:5ZZN

LHG: 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE

LHG is a Ligand Of Interest in 5ZZN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ZZN_LHG_B_621	88%	44%	0.095	0.971	0.83	1.31	2	6	0	0	100%	1
5ZZN_LHG_b_624	88%	52%	0.094	0.968	0.75	1.1	2	5	0	0	100%	1
5ZZN_LHG_D_410	84%	52%	0.117	0.981	0.79	1.07	3	2	0	0	100%	1
5ZZN_LHG_D_409	83%	36%	0.098	0.955	0.9	1.61	3	6	0	0	100%	1
5ZZN_LHG_d_410	82%	52%	0.114	0.971	0.63	1.23	1	5	0	0	100%	1
5ZZN_LHG_d_409	81%	36%	0.116	0.969	0.89	1.62	2	4	0	0	100%	1
5ZZN_LHG_D_411	72%	43%	0.11	0.952	1.12	1.08	3	4	0	0	90%	0.898
5ZZN_LHG_d_411	65%	48%	0.127	0.946	1.03	0.99	3	5	0	0	90%	0.898
5ZZN_LHG_f_102	49%	44%	0.144	0.902	1.08	1.07	2	5	0	0	94%	0.9388
5ZZN_LHG_F_103	44%	30%	0.15	0.916	1.21	1.58	2	4	0	0	78%	0.7755
5ZZN_LHG_e_101	14%	47%	0.225	0.812	1.12	0.95	2	2	0	0	78%	0.7755
5ZZN_LHG_E_101	9%	49%	0.252	0.739	1.04	0.94	2	2	0	0	100%	1
5GTI_LHG_L_101	99%	46%	0.045	0.971	0.91	1.17	2	4	0	0	100%	1
5V2C_LHG_l_101	98%	46%	0.068	0.987	0.91	1.18	2	3	0	0	100%	1
5WS6_LHG_d_407	96%	53%	0.063	0.973	0.89	0.91	3	3	0	0	100%	1
5B5E_LHG_D_410	94%	49%	0.068	0.967	0.83	1.13	2	2	0	0	100%	1
7RF1_LHG_D_410	91%	47%	0.087	0.974	0.92	1.14	2	5	0	0	100%	1
8IRC_LHG_L_101	91%	47%	0.092	0.978	0.88	1.15	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.